- WHO Slams COVID-19 Booster Shots in Wealthy Nations
- Time to Rethink Suicide Warnings on Labels for Anti-Seizure Meds?
- Wuhan Tests All Residents as Delta Variant Rages Where Pandemic Began
- AHA News: She Couldn’t Put Up Her Arms on a Roller Coaster. A Stroke Followed.
- Full Approval of Pfizer COVID Vaccine Could Come in September
- Biden Offers COVID Vaccines to Migrants in Custody Along Mexican Border
- Regeneron Drug Approved to Help Prevent Severe COVID in Vulnerable After Exposure
- Health Highlights: Aug. 4, 2021
- How the Delta Variant Is Changing the U.S. Forecast for COVID-19
- Changing Diets Mean More Americans Are Anemic Now
New Weapon May Help Battle Bird Flu
THURSDAY, Dec. 24Based on findings in animals, researchers are reporting that a new compound may be a better choice for treating bird flu — also known as avian influenza (H5N1) — than the antiviral Tamiflu.
“H5N1 virus is so pathogenic even Tamiflu doesn’t protect all the infected animals. This compound works much better, even three days after infection,” study senior author Yoshihiro Kawaoka, a University of Wisconsin-Madison virologist, said in a university news release.
The researchers tested the compound in mice and found that it was effective against H5N1, seasonal flu and the H1N1 virus. But tests in humans aren’t complete: the third phase of testing, in Japan, has yet to begin.
The compound, known as T-705, could give doctors a new weapon against strains of flu that are resistant to Tamiflu, the study authors noted.
The findings are published online in this week’s issue of the Proceedings of the National Academy of Sciences.
More information
The U.S. Centers for Disease Control and Prevention has more on avian flu.
Source: HealthDay
